Mo1131: HIGHLY SPECIFIC PROMOTER METHYLATION MARKERS FOR MALIGANT STRATIFICATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMSChhoda A, Sharma A, Tang H, Tan W, Sailo B, Peters N, Ying L, Ruzgar N, Kunstman J, Salem R, Farrell J, Ahuja N. Mo1131: HIGHLY SPECIFIC PROMOTER METHYLATION MARKERS FOR MALIGANT STRATIFICATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS Gastroenterology 2022, 162: s-708. DOI: 10.1016/s0016-5085(22)61664-0.
Tu1185: DOES CURRENT EVIDENCE SUPPORT CYST GROWTH RATE AS A WORRISOME FEATURE? A SYSTEMATIC REVIEW AND META-ANALYSISSingh S, Chhoda A, Vodusek Z, Khatri R, Gunderson C, McCarty T, Sharma P, Grimshaw A, Kunstman J, Sharma A, Ahuja N, Gonda T, Farrell J. Tu1185: DOES CURRENT EVIDENCE SUPPORT CYST GROWTH RATE AS A WORRISOME FEATURE? A SYSTEMATIC REVIEW AND META-ANALYSIS Gastroenterology 2022, 162: s-907. DOI: 10.1016/s0016-5085(22)62148-6.
1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASEKhatri R, Chhoda A, Sharma A, Farrell J, Ahuja N, Ehrlich A, Friedenberg F. 1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASE Gastroenterology 2022, 162: s-270-s-271. DOI: 10.1016/s0016-5085(22)60641-3.
Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut C, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay J, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty V, Canter R, Mullen J, Pennacchioli E, van Houdt W, Swallow C, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria S. Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Annals Of Surgical Oncology 2022, 29: 4391-4391. DOI: 10.1245/s10434-022-11601-5.
Abstract PO-155: Racial heterogeneity in the molecular landscape of pancreatic adenocarcinoma: A call for actionLarson H, Chhoda A, Hengartner A, Hasan N, Ruzgar N, Yalamanchi S, Kunstman J, Farrell J, Sharma A, Ahuja N. Abstract PO-155: Racial heterogeneity in the molecular landscape of pancreatic adenocarcinoma: A call for action Cancer Epidemiology Biomarkers & Prevention 2022, 31: po-155-po-155. DOI: 10.1158/1538-7755.disp21-po-155.
1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceHeumann T, Baretti M, Sugar E, Durhman J, Liden S, Miles T, Lopez-Vidal T, Leatherman J, Sharma A, Ahuja N, Weekes C, O'Dwyer P, Monga D, Binder K, Azad N. 1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence Annals Of Oncology 2021, 32: s1087-s1088. DOI: 10.1016/j.annonc.2021.08.797.
Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015Cheng E, Cheng E, Blackburn H, Ng K, Ng K, Spiegelman D, Irwin M, Ma X, Gross C, Tabung F, Tabung F, Giovannucci E, Giovannucci E, Kunz P, Llor X, Billingsley K, Meyerhardt J, Meyerhardt J, Ahuja N, Fuchs C. Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015 Cancer Research 2021, 81: 898-898. DOI: 10.1158/1538-7445.am2021-898.
ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut C, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay J, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty V, Canter R, Mullen J, Pennacchioli E, van Houdt W, Swallow C, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria S. ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Annals Of Surgical Oncology 2021, 28: 490-491. DOI: 10.1245/s10434-021-10095-x.
Sa298 IS IT SAFE TO STOP SURVEILLANCE OF PANCREATIC CYSTS AFTER 5 YEARS OF STABILITY?: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CURRENT EVIDENCE.Chhoda A, Singh S, Sheth A, Sharma P, Sharma A, Kunstman J, Grimshaw A, Ahuja N, Farrell J. Sa298 IS IT SAFE TO STOP SURVEILLANCE OF PANCREATIC CYSTS AFTER 5 YEARS OF STABILITY?: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CURRENT EVIDENCE. Gastroenterology 2021, 160: s-475. DOI: 10.1016/s0016-5085(21)01841-2.
Sa302 IS MULTIFOCALITY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS A RISK FACTOR FOR PANCREATIC MALIGNANCY?: A SYSTEMATIC REVIEW AND META-ANALYSISChhoda A, Singh S, Grimshaw A, Sheth A, Sharma A, Kunstman J, Ahuja N, Farrell J. Sa302 IS MULTIFOCALITY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS A RISK FACTOR FOR PANCREATIC MALIGNANCY?: A SYSTEMATIC REVIEW AND META-ANALYSIS Gastroenterology 2021, 160: s-477. DOI: 10.1016/s0016-5085(21)01845-x.
Abstract PO-015: Hypermethylated genes in leiomyosarcoma can be targeted through guadecitabine treatmentHasan N, De Carvalho Fischer C, Sharma A, Ahuja N. Abstract PO-015: Hypermethylated genes in leiomyosarcoma can be targeted through guadecitabine treatment Cancer Research 2020, 80: po-015-po-015. DOI: 10.1158/1538-7445.epimetab20-po-015.
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.van Houdt WJ, Fiore M, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss D, Gonzalez RJ, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Schrage Y, Cardona K, Pennacchioli E, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria SP, Canter R, Mullen JT, Callegaro D, Fairweather M, Miceli R, Raut CP, Gronchi A, Gladdy RA. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG. Cancer 2020, 126: 4917-4925. PMID: 32797703, DOI: 10.1002/cncr.33139.
Variations in recommended surveillance in colorectal cancer survivorship care plans.Chodoff A, Smith K, Shukla A, Blackford A, Ahuja N, Johnston F, Peairs K, Ngaiza J, Warczynski T, Nettles B, Stotsky-Himelfarb E, Murphy A, Mayonado N, DeSanto J, Snyder C, Choi Y. Variations in recommended surveillance in colorectal cancer survivorship care plans. Journal Of Clinical Oncology 2020, 38: 13-13. DOI: 10.1200/jco.2020.38.29_suppl.13.
22 Poster Discussion A phase II study of Guadecitabine (G) with Irinotecan (IRI) vs regorafenib or TAS-102 in metastatic colorectal cancer (mCRC) patients (pts)Lee V, Zahurak M, Cercek A, Verheul H, Lenz H, Jones P, Baylin S, Parkinson R, Rami V, Lilly E, Miles T, Brown T, Ahuja N, Khoueiry A, Azad N. 22 Poster Discussion A phase II study of Guadecitabine (G) with Irinotecan (IRI) vs regorafenib or TAS-102 in metastatic colorectal cancer (mCRC) patients (pts) European Journal Of Cancer 2020, 138: s12. DOI: 10.1016/s0959-8049(20)31096-0.
S0101 Clinical and Demographic Predictors of Rapidly Progressive Disease in Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma: Risk Profiling From the National Cancer DatabaseIlagan-Ying Y, Ying L, Ferrucci L, Peters N, Blackburn H, Kunstman J, Ahuja N. S0101 Clinical and Demographic Predictors of Rapidly Progressive Disease in Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma: Risk Profiling From the National Cancer Database The American Journal Of Gastroenterology 2020, 115: s48-s49. DOI: 10.14309/01.ajg.0000702452.53969.ae.
Pandemic Recovery Using a Covid-Minimal Cancer Surgery PathwayBoffa DJ, Judson BL, Billingsley KG, Galeta D, Galeta D, Fontanez P, Odermatt C, Lindner K, Mitchell MR, Henderson CM, Carafeno T, Pinto J, Wagner J, Wagner J, Ancuta M, Beley P, Turner AL, Banack T, Laurans MS, Johnson DC, Yoo P, Morton JM, Zurich H, Davis K, Davis K, Ahuja N. Pandemic Recovery Using a Covid-Minimal Cancer Surgery Pathway The Annals Of Thoracic Surgery 2020, 110: 718-724. PMID: 32417195, PMCID: PMC7227551, DOI: 10.1016/j.athoracsur.2020.05.003.
Abstract B23: Bioadhesive nanoparticles as a delivery vehicle in pancreatic cancer epithelial cells and pancreatic fibroblastsHasan N, Suh H, Saltzman M, Ahuja N. Abstract B23: Bioadhesive nanoparticles as a delivery vehicle in pancreatic cancer epithelial cells and pancreatic fibroblasts Cancer Research 2019, 79: b23-b23. DOI: 10.1158/1538-7445.panca19-b23.
Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunitiesBaretti M, Ahuja N, Azad N. Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities Annals Of Pancreatic Cancer 2019, 2: 18-18. DOI: 10.21037/apc.2019.10.01.
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow C, Bagaria SP, Canter RJ, Mullen JT, Gelderblom H, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2019, 25: 2664-2671. PMID: 30723141, DOI: 10.1158/1078-0432.CCR-18-2700.
Epigenetic priming prior to pembrolizumab in mismatch repair-proficient advanced colorectal cancer.Murphy A, Walker R, Lutz E, Parkinson R, Ahuja N, Zheng L, Jaffee E, Azad N. Epigenetic priming prior to pembrolizumab in mismatch repair-proficient advanced colorectal cancer. Journal Of Clinical Oncology 2019, 37: 591-591. DOI: 10.1200/jco.2019.37.4_suppl.591.
Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection CriteriaHanada Y, Choi AY, Hwang JH, Draganov PV, Khanna L, Sethi A, Bartel MJ, Goel N, Abe S, De Latour RA, Park K, Melis M, Newman E, Hatzaras I, Reddy SS, Farma JM, Liu X, Schlachterman A, Kresak J, Trapp G, Ansari N, Schrope B, Lee JY, Dhall D, Lo S, Jamil LH, Burch M, Gaddam S, Gong Y, Del Portillo A, Tomizawa Y, Truong CD, Brewer Gutierrez OI, Montgomery E, Johnston FM, Duncan M, Canto M, Ahuja N, Lennon AM, Ngamruengphong S. Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria Clinical Gastroenterology And Hepatology 2018, 17: 1763-1769. PMID: 30471457, DOI: 10.1016/j.cgh.2018.11.031.
High-Dose Rate Brachytherapy Increases Disease-Free Survival for Retroperitoneal SarcomasSingh J, Gani F, Shankar N, Canner J, Overton H, Blair A, Lerner L, Narang A, Johnston F, Ahuja N. High-Dose Rate Brachytherapy Increases Disease-Free Survival for Retroperitoneal Sarcomas Journal Of The American College Of Surgeons 2018, 227: s239-s240. DOI: 10.1016/j.jamcollsurg.2018.07.629.
Ensuring Equity, Diversity, and Inclusion in Academic SurgeryWest MA, Hwang S, Maier RV, Ahuja N, Angelos P, Bass BL, Brasel KJ, Chen H, Davis KA, Eberlein TJ, Fong Y, Greenberg CC, Lillemoe KD, McCarthy MC, Michelassi F, Numann PJ, Parangi S, Reyes JD, Sanfey HA, Stain SC, Weigel RJ, Wren SM. Ensuring Equity, Diversity, and Inclusion in Academic Surgery Annals Of Surgery 2018, 268: 403-407. PMID: 30004923, DOI: 10.1097/sla.0000000000002937.
Abstract A35: Treatment with demethylating drugs inhibits tumor growth in leiomyosarcoma cell lines and xenograft modelsFischer C, Hu Y, Singh J, Thakar M, Thakar M, Ahuja N. Abstract A35: Treatment with demethylating drugs inhibits tumor growth in leiomyosarcoma cell lines and xenograft models Clinical Cancer Research 2018, 24: a35-a35. DOI: 10.1158/1557-3265.sarcomas17-a35.
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AM. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings Of The National Academy Of Sciences Of The United States Of America 2017, 114: 10202-10207. PMID: 28874546, PMCID: PMC5617273, DOI: 10.1073/pnas.1704961114.
Genomics of peritoneal surface malignanciesSingh J, Sharma A, Ahuja N. Genomics of peritoneal surface malignancies Journal Of Peritoneum (and Other Serosal Surfaces) 2017, 2 DOI: 10.4081/joper.2017.62.
Mo1163 A Multicenter Study Evaluating Risk Factors of Lymph Node Metastasis in Early Gastric Cancer in the United StatesGutierrez O, Choi A, Draganov P, Khanna L, Sethi A, Bartel M, Abe S, Ali R, Park K, Melis M, Newman E, Hatzaras I, Hwang J, Reddy S, Farma J, Liu X, Schlachterman A, Kresak J, Gaddam S, Hanada Y, Montgomery E, Johnston F, Duncan M, Canto M, Ahuja N, Lennon A, Ngamruengphong S. Mo1163 A Multicenter Study Evaluating Risk Factors of Lymph Node Metastasis in Early Gastric Cancer in the United States Gastrointestinal Endoscopy 2017, 85: ab444. DOI: 10.1016/j.gie.2017.03.1034.
MP65-20 EPIGENETIC PRIMING WITH 5-AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTSYoshida T, Sharma A, Kates M, Sopko N, Liu X, Hahn N, McConkey D, Ahuja N, Bivalacqua T. MP65-20 EPIGENETIC PRIMING WITH 5-AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS Investigative Urology 2017, 197: e861. DOI: 10.1016/j.juro.2017.02.2014.
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.Masica DL, Dal Molin M, Wolfgang CL, Tomita T, Ostovaneh MR, Blackford A, Moran RA, Law JK, Barkley T, Goggins M, Irene Canto M, Pittman M, Eshleman JR, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Ahuja N, Makary MA, Weiss MJ, Hirose K, Cameron JL, Rezaee N, He J, Joon Ahn Y, Wu W, Wang Y, Springer S, Diaz LL, Papadopoulos N, Hruban RH, Kinzler KW, Vogelstein B, Karchin R, Lennon AM. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts. Journal Of The American Medical Informatics Association : JAMIA 2017, 24: 145-152. PMID: 27330075, PMCID: PMC5201184, DOI: 10.1093/jamia/ocw069.
O1-10-3 Associations of IGFBP3 SNPs, methylation and recurrence risk in patients with stage II colorectal cancerFu T, Li F, Ye J, Liu Z, Wolfgang C, Iacobuzio-Donahue C, Tong W, Liu B, Ahuja N. O1-10-3 Associations of IGFBP3 SNPs, methylation and recurrence risk in patients with stage II colorectal cancer Annals Of Oncology 2016, 27: vii78. DOI: 10.1093/annonc/mdw521.016.
Innovative Two-Stage Process to Standardize Best Practices to Improve Patient MortalityAhuja V, Sheikh S, Castronuovo J, Ahuja N. Innovative Two-Stage Process to Standardize Best Practices to Improve Patient Mortality Journal Of The American College Of Surgeons 2016, 223: e170. DOI: 10.1016/j.jamcollsurg.2016.08.432.
Passive Hyperspectral Sensing Reliably Identifies Colorectal Cancer in Intraoperative Colon SpecimensBeaulieu R, Goldstein S, Banerjee A, Safar B, Ahuja N. Passive Hyperspectral Sensing Reliably Identifies Colorectal Cancer in Intraoperative Colon Specimens Journal Of The American College Of Surgeons 2016, 223: s34. DOI: 10.1016/j.jamcollsurg.2016.06.087.
Abstract CT017: A phase I study of guadecitabine (GUA) combined with irinotecan (IRI) in previously treated metastatic colorectal cancer (mCRC) patientsLee V, Wang J, El Khoueiry A, Verheul H, Gootjes E, Sharma A, Kerner Z, Jones P, Baylin S, Lilly E, Ahuja N, Brown T, Azad N. Abstract CT017: A phase I study of guadecitabine (GUA) combined with irinotecan (IRI) in previously treated metastatic colorectal cancer (mCRC) patients Cancer Research 2016, 76: ct017-ct017. DOI: 10.1158/1538-7445.am2016-ct017.
Passive hyperspectral sensing to identify colorectal cancer in intraoperative colon specimens.Beaulieu R, Goldstein S, Banerjee A, Safar B, Ahuja N. Passive hyperspectral sensing to identify colorectal cancer in intraoperative colon specimens. Journal Of Clinical Oncology 2016, 34: e15161-e15161. DOI: 10.1200/jco.2016.34.15_suppl.e15161.
Epigenetic priming prior to pembrolizumab in microsatellite-stable (MSS) advanced colorectal cancer.Murphy A, White S, Walker R, Lutz E, Ahuja N, Zheng L, Jaffee E, Azad N. Epigenetic priming prior to pembrolizumab in microsatellite-stable (MSS) advanced colorectal cancer. Journal Of Clinical Oncology 2016, 34: tps3626-tps3626. DOI: 10.1200/jco.2016.34.15_suppl.tps3626.
Cystic lesions of the pancreas: Why we get it wrongManos L, Moran R, Rezaee N, Hruban R, Fishman E, Ahuja N, Cameron J, He J, Weiss M, Lennon A, Wolfgang C. Cystic lesions of the pancreas: Why we get it wrong Hepato Pancreato Biliary 2016, 18: e337. DOI: 10.1016/j.hpb.2016.02.873.
MP23-12 INTRAOPERATIVE RADIATION THERAPY DURING GENITOURINARY SURGERY: THE IMPORTANCE OF SPECIMEN MARGIN STATUS IN IMPROVING SURVIVALChappidi M, Kates M, Schwen Z, Sopko N, Tran P, Ahuja N, Terezakis S, Pierorazio P, Bivalacqua T. MP23-12 INTRAOPERATIVE RADIATION THERAPY DURING GENITOURINARY SURGERY: THE IMPORTANCE OF SPECIMEN MARGIN STATUS IN IMPROVING SURVIVAL Investigative Urology 2016, 195: e266. DOI: 10.1016/j.juro.2016.02.734.
DNA methylation changes in extracellular remodeling pathway genes during the transformation of human mesenchymal stem cellsKim T, Park S, Kim H, Ahuja N, Yi J. DNA methylation changes in extracellular remodeling pathway genes during the transformation of human mesenchymal stem cells Genes & Genomics 2016, 38: 611-617. DOI: 10.1007/s13258-016-0402-x.
Chapter 11 Prognostic EpigeneticsSharma A, Abdelfatah E, Eissa M, Ahuja N. Chapter 11 Prognostic Epigenetics 2016, 177-195. DOI: 10.1016/b978-0-12-803239-8.00011-9.
A combination of molecular markers and clinical features improve the classification of pancreatic cysts.Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD, Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology 2015, 149: 1501-10. PMID: 26253305, PMCID: PMC4782782, DOI: 10.1053/j.gastro.2015.07.041.
Standard Fractionation External Beam Radiation Therapy With and Without Intraoperative Radiation Therapy for Patients With Locally Recurrent Rectal CancerKishan A, Moningi S, Kumar R, Ancukiewicz M, Ahuja N, Gearhart S, Efron J, Herman J, Hong T. Standard Fractionation External Beam Radiation Therapy With and Without Intraoperative Radiation Therapy for Patients With Locally Recurrent Rectal Cancer International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e145. DOI: 10.1016/j.ijrobp.2015.07.918.
Early outcomes after elective colorectal surgery in end stage renal disease (ESRD) vs non-ESRD PatientsArhuidese I, Malas M, Obeid T, Qazi U, Ahuja N, Efron J. Early outcomes after elective colorectal surgery in end stage renal disease (ESRD) vs non-ESRD Patients Journal Of The American College Of Surgeons 2015, 221: e59. DOI: 10.1016/j.jamcollsurg.2015.08.052.
Epidemiology and treatment outcome among patients with desmoplastic small round cell tumorsJuo Y, Meyer C, Thornton K, Herman J, Terezakis S, Ahuja N. Epidemiology and treatment outcome among patients with desmoplastic small round cell tumors Journal Of The American College Of Surgeons 2015, 221: e128. DOI: 10.1016/j.jamcollsurg.2015.08.243.
Adaptive immune resistance in gastro-esophageal cancer: Correlating tumoral/stromal PDL1 expression with CD8
+
cell count.Kelly R, Thompson E, Zahurak M, Cornish T, Cuka N, Abdelfatah E, Taube J, Yang S, Duncan M, Ahuja N, Murphy A, Anders R. Adaptive immune resistance in gastro-esophageal cancer: Correlating tumoral/stromal PDL1 expression with CD8
+
cell count. Journal Of Clinical Oncology 2015, 33: 4031-4031. DOI: 10.1200/jco.2015.33.15_suppl.4031.
A phase I trial of oral 5-azacitidine in combination with romidepsin in advanced solid tumors with an expansion cohort in virally mediated cancers and liposarcoma.Reiss K, Rudek M, Sartorius-Mergenthaler S, Downs M, Cosgrove D, Gaillard S, Baylin S, Ahuja N, Azad N. A phase I trial of oral 5-azacitidine in combination with romidepsin in advanced solid tumors with an expansion cohort in virally mediated cancers and liposarcoma. Journal Of Clinical Oncology 2015, 33: tps2619-tps2619. DOI: 10.1200/jco.2015.33.15_suppl.tps2619.
A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence.Reiss K, Ahuja N, Baylin S, Mauro L, Linden S, White S, Laheru D, Herman J, Wolfgang C, Weiss M, Cameron J, Makary M, Azad N. A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence. Journal Of Clinical Oncology 2015, 33: tps4144-tps4144. DOI: 10.1200/jco.2015.33.15_suppl.tps4144.
A phase I study of investigational agent SGI-110 combined with irinotecan in previously treated metastatic colorectal cancer patients.Wang J, Gootjes E, Uram J, Zahurak M, El-Khoueiry A, Verheul H, Ahuja N, Azad N. A phase I study of investigational agent SGI-110 combined with irinotecan in previously treated metastatic colorectal cancer patients. Journal Of Clinical Oncology 2015, 33: tps797-tps797. DOI: 10.1200/jco.2015.33.3_suppl.tps797.
Portal/superior mesenteric vein resection during pancreatic surgery: evolution of technique and lessons learnedWesson R, Leng J, Schulick R, Weiss M, Wolfgang C, Ahuja N, Pawlik T, Hirose K, Cameron J, Cameron A. Portal/superior mesenteric vein resection during pancreatic surgery: evolution of technique and lessons learned Journal Of The American College Of Surgeons 2014, 219: e114. DOI: 10.1016/j.jamcollsurg.2014.07.691.
Association of recurrence patterns following resection of pancreatic adenocarcinoma with overall survival.He J, Rezaee N, Wu W, Cameron J, Ahuja N, Pawlik T, Herman J, Hruban R, Weiss M, Zheng L, Wolfgang C. Association of recurrence patterns following resection of pancreatic adenocarcinoma with overall survival. Journal Of Clinical Oncology 2014, 32: 4127-4127. DOI: 10.1200/jco.2014.32.15_suppl.4127.
Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer.Connolly R, Jankowitz R, Zahnow C, Zhang Z, Rudek M, Slater S, Powers P, Jeter S, Brufsky A, Piekarz R, Herman J, Ahuja N, Somlo G, Garcia A, Baylin S, Davidson N, Stearns V. Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer. Journal Of Clinical Oncology 2014, 32: 569-569. DOI: 10.1200/jco.2014.32.15_suppl.569.
Prognostic factors after pancreaticoduodenectomy for duodenal adenocarcinoma: Results from a dual center analysis.He J, Kwon W, Wu W, Cameron J, Hruban R, Weiss M, Ahuja N, Pawlik T, Jang J, Wolfgang C. Prognostic factors after pancreaticoduodenectomy for duodenal adenocarcinoma: Results from a dual center analysis. Journal Of Clinical Oncology 2014, 32: e15181-e15181. DOI: 10.1200/jco.2014.32.15_suppl.e15181.
Assessing the Experience in Complex Hepatopancreatobiliary Surgery Among Graduating Chief Residents: Is the Operative Caseload Enough?Sachs T, Ejaz A, Weiss M, Spolverato G, Ahuja N, Makary M, Wolfgang C, Hirose K, Pawlik T. Assessing the Experience in Complex Hepatopancreatobiliary Surgery Among Graduating Chief Residents: Is the Operative Caseload Enough? Journal Of Surgical Research 2014, 186: 546. DOI: 10.1016/j.jss.2013.11.439.
Hospital Volume and Patient Outcomes in Hepato-Pancreato-Biliary Surgery: is Assessing Differences in Mortality Enough?Schneider E, Ejaz A, Spolverato G, Haider A, Makary M, Wolfgang C, Ahuja N, Weiss M, Pawlik T. Hospital Volume and Patient Outcomes in Hepato-Pancreato-Biliary Surgery: is Assessing Differences in Mortality Enough? Journal Of Surgical Research 2014, 186: 520. DOI: 10.1016/j.jss.2013.11.355.
Black and Hispanic Pancreaticoduodenectomy Patients Are Treated by Lower Volume Providers and Have Longer Hospital Stays Compared with White PatientsSchneider E, Calkins K, Weiss M, Wolfgang C, Makary M, Ahuja N, Haider A, Pawlik T. Black and Hispanic Pancreaticoduodenectomy Patients Are Treated by Lower Volume Providers and Have Longer Hospital Stays Compared with White Patients Journal Of Surgical Research 2014, 186: 607-608. DOI: 10.1016/j.jss.2013.11.584.
Inpatient Survival after Gastrectomy for Gastric Cancer in the 21st Century: Are We Making Progress?Wang H, Pawlik T, Duncan M, Hui X, Selvarajah S, Canner J, Haider A, Ahuja N, Schneider E. Inpatient Survival after Gastrectomy for Gastric Cancer in the 21st Century: Are We Making Progress? Journal Of Surgical Research 2014, 186: 683. DOI: 10.1016/j.jss.2013.11.946.
A Comparison of Open and Minimally Invasive Surgery for Hepatic & Pancreatic Resections Using the Nationwide Inpatient Sample (NIS)Ejaz A, Sachs T, Spolverato G, Ahuja N, Makary M, Wolfgang C, Hirose K, Weiss M, Pawlik T. A Comparison of Open and Minimally Invasive Surgery for Hepatic & Pancreatic Resections Using the Nationwide Inpatient Sample (NIS) Journal Of Surgical Research 2014, 186: 641-642. DOI: 10.1016/j.jss.2013.11.665.
MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancerPelosof L, Yerram S, Ahuja N, Delmas A, Danilova L, Herman J, Azad N. MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer European Journal Of Cancer 2013, 49: s33. DOI: 10.1016/s0959-8049(13)70182-5.
Cost and outcomes analysis of robotic, laparoscopic, and open colon resection: a national studyJuo Y, Hyder O, Haider A, Camp M, Lidor A, Ahuja N. Cost and outcomes analysis of robotic, laparoscopic, and open colon resection: a national study Journal Of The American College Of Surgeons 2013, 217: s112-s113. DOI: 10.1016/j.jamcollsurg.2013.07.260.
A phase II study of combination epigenetic therapy in metastatic colorectal cancer (mCRC): A phase II consortium (P2C)/Stand Up 2 Cancer (SU2C) study.Azad N, El-Khoueiry A, Mahoney M, Adkins D, Flynn P, Bahary N, Kim G, Pitot H, Erlichman C, Donehower R, Herman J, Baylin S, Ahuja N. A phase II study of combination epigenetic therapy in metastatic colorectal cancer (mCRC): A phase II consortium (P2C)/Stand Up 2 Cancer (SU2C) study. Journal Of Clinical Oncology 2013, 31: 3539-3539. DOI: 10.1200/jco.2013.31.15_suppl.3539.
Abstract 4666: A phase 2 study investigating the safety, efficacy and surrogate biomarkers of response of 5-azacitidine (5-AZA) andentinostat (MS-275) in patients with triple-negative advanced breast cancer.Connolly R, Jankowitz R, Zahnow C, Zhang Z, Rudek M, Jeter S, Slater S, Powers P, Wolff A, Fetting J, Brufsky A, Piekarz R, Ahuja N, Somlo G, Garcia A, Baylin S, Davidson N, Stearns V. Abstract 4666: A phase 2 study investigating the safety, efficacy and surrogate biomarkers of response of 5-azacitidine (5-AZA) andentinostat (MS-275) in patients with triple-negative advanced breast cancer. Cancer Research 2013, 73: 4666-4666. DOI: 10.1158/1538-7445.am2013-4666.
Discovery of early detection markers of pancreatic cancer and clinical application in blood-based screeningKwak R, Keeley B, Guzzetta A, Jeschke J, Wolfgang C, Wang T, Herman J, Iacobuzio-Donahue C, Ahuja N. Discovery of early detection markers of pancreatic cancer and clinical application in blood-based screening Pancreatology 2013, 13: e46. DOI: 10.1016/j.pan.2012.12.216.
Improving Sensitivity to Irinotecan Using 5-Azacytidine in Colon Cancer Cell LinesVatapalli R, Guzzetta A, Fu T, Syed L, Kwak R, Ahuja N. Improving Sensitivity to Irinotecan Using 5-Azacytidine in Colon Cancer Cell Lines Journal Of Surgical Research 2013, 179: 251-252. DOI: 10.1016/j.jss.2012.10.474.
Epigenetic Upregulation of Beta-2 Microglobulin in Microsatellite Stable Colon Cancer Cell LinesGuzzetta A, Kwak R, Vatapalli R, Syed L, Koch A, Easwaran H, Baylin S, Ahuja N. Epigenetic Upregulation of Beta-2 Microglobulin in Microsatellite Stable Colon Cancer Cell Lines Journal Of Surgical Research 2013, 179: 339. DOI: 10.1016/j.jss.2012.10.764.
140 Portal/Superior Mesenteric Vein Resections During Pancreaticoduodenectomy: Evolution of Technique and Lessons LearnedCameron A, Wesson R, Leng H, Cameron J, Wolfgang C, Edil B, Choti M, Pawlik T, Makary M, Eckhauser F, Hirose K, Ahuja N, Singer A, Dagher N, Schulick R. 140 Portal/Superior Mesenteric Vein Resections During Pancreaticoduodenectomy: Evolution of Technique and Lessons Learned Journal Of Surgical Research 2013, 179: 241-242. DOI: 10.1016/j.jss.2012.10.451.
Blood-based screening for methylation changes in colorectal cancer patients using novel nanotechnologies.Ahuja N, Kwak R, Keeley B, Stark A, Guzzetta A, Wolfgang C, Herman J, Iacobuzio-Donahue C, Wang T. Blood-based screening for methylation changes in colorectal cancer patients using novel nanotechnologies. Journal Of Clinical Oncology 2013, 31: 384-384. DOI: 10.1200/jco.2013.31.4_suppl.384.
Analysis of Cone BeamCT Shifts in Image Guided Radiation Therapy for Abdominopelvic Soft-tissue SarcomasSharabi A, Alcorn S, Tryggestad E, Ahuja N, Frassica D, McNutt T, Hales R, Terezakis S. Analysis of Cone BeamCT Shifts in Image Guided Radiation Therapy for Abdominopelvic Soft-tissue Sarcomas International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s659. DOI: 10.1016/j.ijrobp.2012.07.1760.
Abstract 94: Epigenetic silencing of CDO1 sustains viability of breast cancer cells via the reduction of cellular ROSJeschke J, O'Hagan H, Zhang W, Calmon M, Dhir M, van Neste L, Bijsmans I, Gabrielson E, Schuebel K, Baylin S, Winterpacht A, Herman J, Ahuja N. Abstract 94: Epigenetic silencing of CDO1 sustains viability of breast cancer cells via the reduction of cellular ROS Cancer Research 2012, 72: 94-94. DOI: 10.1158/1538-7445.am2012-94.
Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cellsTsai H, Li H, Neste L, Cai Y, Robert C, Rassool F, Shin J, Harbom K, Beaty R, Pappou E, Harris J, Yen R, Ahuja N, Brock M, Stearns V, Feller-Kopman D, Lin Y, Welm A, Issa J, Minn I, Matsui W, Jang Y, Sharkis S, Baylin S, Zahnow C. Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Research 2012, 72: 995-995. DOI: 10.1158/1538-7445.am2012-995.
Lymph Node Evaluation by Tumor Location in Colon Cancer Elderly Patients: A SEER-Medicare StudyTucker J, Yanagawa F, Ahuja N, Bell T, Grim R, Ahuja V. Lymph Node Evaluation by Tumor Location in Colon Cancer Elderly Patients: A SEER-Medicare Study Journal Of Surgical Research 2012, 172: 191. DOI: 10.1016/j.jss.2011.11.095.
Epithelial Sarcomas: Experience From a Single InstitutionGuzzetta A, Montgomery E, Emmanouil P, Fu T, Ahuja N. Epithelial Sarcomas: Experience From a Single Institution Journal Of Surgical Research 2012, 172: 310. DOI: 10.1016/j.jss.2011.11.553.
OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer.Connolly R, Jankowitz R, Andreopoulou E, Allred J, Jeter S, Zorzi J, Adam B, Espinoza-Delgado I, Baylin S, Zahnow C, Ahuja N, Davidson N, Stearns V. OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer. Cancer Research 2011, 71: ot3-01-06-ot3-01-06. DOI: 10.1158/0008-5472.sabcs11-ot3-01-06.
Abstract B43: Early detection biomarker of pancreatic cancer using a nanoparticle-based methylation assayYi J, Bailey V, Downing S, Goggins M, Yang K, Wang T, Herman J, Baylin S, Ahuja N. Abstract B43: Early detection biomarker of pancreatic cancer using a nanoparticle-based methylation assay Cancer Epidemiology Biomarkers & Prevention 2011, 20: b43-b43. DOI: 10.1158/1055-9965.disp-11-b43.
Abstract 2618: DNMT1 as a marker of differential sensitivities to epigenetic therapy of a Kras mutant and Kras wild type human non small cell lung cancer cell lineDu Z, Wrangle J, Pelosky K, Harris J, Shin J, Vendetti F, Hulbert A, Lee B, Zahnow C, Ahuja N, Herman J, Baylin S, Brock M. Abstract 2618: DNMT1 as a marker of differential sensitivities to epigenetic therapy of a Kras mutant and Kras wild type human non small cell lung cancer cell line Cancer Research 2011, 71: 2618-2618. DOI: 10.1158/1538-7445.am2011-2618.
Nurse-Perceived Barriers to Effective Communication Regarding Prognosis and Optimal End-of-Life Care for Surgical ICU Patients: A Qualitative Exploration (314-A)Aslakson R, Wyskiel R, Thornton I, Copley C, Shaffer D, Zyra M, Ahuja N, Nelson J, Pronovost P. Nurse-Perceived Barriers to Effective Communication Regarding Prognosis and Optimal End-of-Life Care for Surgical ICU Patients: A Qualitative Exploration (314-A) Journal Of Pain And Symptom Management 2011, 41: 193. DOI: 10.1016/j.jpainsymman.2010.10.051.
9 Stool and Blood Sampling for Early Detection of Colorectal CancerSicklick J, Ahuja N. 9 Stool and Blood Sampling for Early Detection of Colorectal Cancer 2011, 93-105. DOI: 10.1016/b978-1-4160-4686-8.50014-2.
5 Behavior and Dietary Modification in the Prevention of Colon CancerDowning S, Pappou E, Ahuja N. 5 Behavior and Dietary Modification in the Prevention of Colon Cancer 2011, 47-64. DOI: 10.1016/b978-1-4160-4686-8.50010-5.
Use of [18F]-2-Fluoro-2-deoxy-D-glucose Positron Emission Tomography in the Management of Colorectal CancerTsai S, Jacene H, Ahuja N. Use of [18F]-2-Fluoro-2-deoxy-D-glucose Positron Emission Tomography in the Management of Colorectal Cancer 2011, 200-204. DOI: 10.1016/b978-1-4377-0823-3.10049-9.
A Bioinformatics Pipeline for Cancer EpigeneticsVan Neste L, G. Herman J, E. Schuebel K, Cope L, B. Baylin S, Van Criekinge W, Ahuja N. A Bioinformatics Pipeline for Cancer Epigenetics Current Bioinformatics 2010, 5: 153-163. DOI: 10.2174/157489310792006710.
M1629 Preoperative Biopsy Findings Correlate Poorly With Postoperative Findings in IBD-Associated NeoplasiaGearhart S, Wick E, Ahuja N, Montgomery E, Efron J. M1629 Preoperative Biopsy Findings Correlate Poorly With Postoperative Findings in IBD-Associated Neoplasia Gastroenterology 2010, 138: s-870. DOI: 10.1016/s0016-5085(10)64018-8.
Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor responseTsai H, Van Neste L, Li H, Cai Y, Robert C, Shin J, Pappou E, Yen R, Minn I, Ahuja N, Brock M, Rassool F, Jang Y, Sharkis S, Matsui W, Zahnow C, Baylin S. Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor response Cancer Research 2010, 70: lb-88-lb-88. DOI: 10.1158/1538-7445.am10-lb-88.
12LBA A Plasma-based colorectal cancer (CRC) screening assay using DNA methylation markers - first results of multicenter studiesLouwagie J, Pommerien W, Brichard G, Otto G, Van Criekinge W, Baylin S, Ahuja N, Adams H, Nürnberg D, Bierau K. 12LBA A Plasma-based colorectal cancer (CRC) screening assay using DNA methylation markers - first results of multicenter studies European Journal Of Cancer Supplements 2009, 7: 9. DOI: 10.1016/s1359-6349(09)72047-6.
Asian race as a risk factor for bile duct injury during cholecystectomyDatoo G, Downing S, Oyetunji T, Fullum T, Chang D, Ahuja N. Asian race as a risk factor for bile duct injury during cholecystectomy Journal Of The American College Of Surgeons 2009, 209: s24. DOI: 10.1016/j.jamcollsurg.2009.06.046.
W1755 Exploring Combination Epigenetic Therapy for the Treatment of Colorectal CancerDhir M, Calmon M, Jeschke J, Azad N, Herman J, Baylin S, Ahuja N. W1755 Exploring Combination Epigenetic Therapy for the Treatment of Colorectal Cancer Gastroenterology 2009, 136: a-934. DOI: 10.1016/s0016-5085(09)64324-9.
M1592 Is There Any Role for Resection for Stage IV Gastric Cancers?Downing S, Dhir M, Frederick W, Oyetunji T, Wolfgang C, Schulick R, Chang D, Ahuja N. M1592 Is There Any Role for Resection for Stage IV Gastric Cancers? Gastroenterology 2009, 136: a-903. DOI: 10.1016/s0016-5085(09)64174-3.
55: Early Methylation of SYNE1 in Colorectal Cancer: Implications for Stool-Based Colorectal Cancer ScreeningDhir M, Glockner S, Van Neste L, Schuebel K, Baylin S, Ahuja N. 55: Early Methylation of SYNE1 in Colorectal Cancer: Implications for Stool-Based Colorectal Cancer Screening Journal Of Surgical Research 2009, 151: 195-196. DOI: 10.1016/j.jss.2008.11.065.
QS47. Age and Racial Disparities in Access to High Volume Centers for Colorectal Cancer. Who Makes the Cut?Hayanga A, Mukherjee D, Chang D, Kaiser H, Gearhart S, Ahuja N, Freischlag J. QS47. Age and Racial Disparities in Access to High Volume Centers for Colorectal Cancer. Who Makes the Cut? Journal Of Surgical Research 2009, 151: 284. DOI: 10.1016/j.jss.2008.11.340.
QS277. The Effect of Teaching Hospital Status on Operative Mortality and Outcomes Following Colorectal Cancer ResectionHayanga A, Mukherjee D, Chang D, Kaiser H, Gearhart S, Ahuja N, Freischlag J. QS277. The Effect of Teaching Hospital Status on Operative Mortality and Outcomes Following Colorectal Cancer Resection Journal Of Surgical Research 2009, 151: 295. DOI: 10.1016/j.jss.2008.11.581.
Syne1 Promoter Hypermethylation as a Predictor of Tumor Aggressiveness in Primary Breast CancerRimner A, Ho A, Ahuja N, Schuebel K, Baylin S, Gerald W, Chan T. Syne1 Promoter Hypermethylation as a Predictor of Tumor Aggressiveness in Primary Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s681-s682. DOI: 10.1016/j.ijrobp.2008.06.563.
557 Epigenetic Regulation of WNT Signaling Pathway Genes in Inflammatory Bowel Disease (IBD) NeoplasiaDhir M, Montgomery E, Schuebel K, Gearhart S, Ahuja N. 557 Epigenetic Regulation of WNT Signaling Pathway Genes in Inflammatory Bowel Disease (IBD) Neoplasia Gastroenterology 2008, 134: a-848-a-849. DOI: 10.1016/s0016-5085(08)63975-x.
42. Utilization of Genomic Approaches to Identify the Hypermethylome of Colorectal Cancer - A Strategy for Biomarker DiscoveryAhuja N, Schuebel K, Glockner S, Dhir M, Van Neste L, Yi J, Herman J, Baylin S. 42. Utilization of Genomic Approaches to Identify the Hypermethylome of Colorectal Cancer - A Strategy for Biomarker Discovery Journal Of Surgical Research 2008, 144: 194. DOI: 10.1016/j.jss.2007.12.049.
Subclassification of microsatellite-unstable tumors in colorectal cancerAhuja N, Baylin S. Subclassification of microsatellite-unstable tumors in colorectal cancer Current Colorectal Cancer Reports 2007, 3: 212-219. DOI: 10.1007/s11888-007-0033-3.
Potential pitfalls associated with using a cut-point of 12 lymph nodes as a quality of care measure for patients with NO adenocarcinoma of the colonSlidell M, Ahuja N, Evangelista R, White J, Evans S, Kreishman P, Chang D. Potential pitfalls associated with using a cut-point of 12 lymph nodes as a quality of care measure for patients with NO adenocarcinoma of the colon Journal Of The American College Of Surgeons 2007, 205: s72. DOI: 10.1016/j.jamcollsurg.2007.06.179.
80 What constitutes a “high volume” hospital for pancreatic resection?Meguid R, Ahuja N, Chang D. 80 What constitutes a “high volume” hospital for pancreatic resection? Journal Of Surgical Research 2007, 137: 184-185. DOI: 10.1016/j.jss.2006.12.091.
Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal CancerSchuebel K, Chen W, Cope L, Glockner S, Suzuki H, Yi J, Chan T, Van Neste L, Van Criekinge W, van den Bosch S, van Engeland M, Ting A, Jair K, Yu W, Toyota M, Imai K, Ahuja N, Herman J, Baylin S. Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer PLOS Genetics 2005, preprint: e157. DOI: 10.1371/journal.pgen.0030157.eor.